T

The Oregon Clinic | Pulmonary Critical Care & Sleep Medicine East

Research site
(Unclaimed)
Location
1111 NE 99th Avenue Suite 200, Portland, Oregon, United States of America

Site insights

Top conditions

Top treatments

Nintedanib
Droxidopa
Treprostinil
BI 1015550
Tiotropium
Sildenafil
Guselkumab
Macitentan
Lebrikizumab
Sitaxsentan

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 46 total trials

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects wit...

Enrolling
Urinary Urge Incontinence
Incontinence, Urinary
Device: eCoin Tibial Nerve Stimulation
Locations recently updated

The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.

Enrolling
Crohn's Disease
Biological: JNJ-78934804
Biological: Golimumab
Locations recently updated

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.

Active, not recruiting
Crohn Disease
Drug: Guselkumab Dose 3
Drug: Placebo
Locations recently updated

This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COP...

Enrolling
Chronic Obstructive Pulmonary Disease (COPD)
Drug: Astegolimab
Drug: Placebo

This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older....

Active, not recruiting
Idiopathic Pulmonary Fibrosis
Drug: Placebo
Drug: BI 1015550

This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic...

Active, not recruiting
Lung Diseases, Interstitial
Drug: BI 1015550
Drug: Placebo

Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis.

Invitation-only
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Device: Treprostinil Ultrasonic Nebulizer
Drug: Inhaled Treprostinil
Locations recently updated

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committe...

Enrolling
Pulmonary Arterial Hypertension
Drug: Placebo
Drug: Macitentan 75 mg

Trial sponsors

Boehringer Ingelheim logo
Actelion Pharmaceuticals logo
United Therapeutics logo
T
C
J
Roche logo
T
A
Baxter logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems